Cadila Healthcare - Convergence of moving averages

111
Another stock along with IPCA which would benefit from the current demand for hydrochloroquine. Marked prices are 2 places where stock can be purchased.

SL below 200EMA.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。